Literature DB >> 25056610

The mental health of asbestos-exposed subjects with pleural abnormalities.

Peter Franklin1, Monique Robinson, Patrick Abaogye-Sarfo, Latha Samuel, Nola Olsen, Rob Mina, A W Musk, Alison Reid.   

Abstract

PURPOSE: To examine the effect of knowledge of radiographic abnormalities on the mental health of asbestos-exposed people with and without pleural abnormalities.
METHODS: Subjects were former asbestos mine and mill workers and residents of the mining town who had participated in an annual health review program. Pleural abnormalities (pleural plaques, diffuse pleural thickening and asbestosis) were determined from plain chest X-rays. All Participants completed a questionnaire on mental health status (SF-12) and locus of control (LOC).
RESULTS: There were no significant differences between asbestos-exposed people with and without radiographic abnormalities for either the SF-12 mental health score or LOC. However, the asbestos-exposed cohorts had lower mental health scores compared with a random sample of the local population.
CONCLUSION: The presence of pleural abnormalities did not further affect the mental health of asbestos-exposed people beyond a decrement associated with exposure per se.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056610     DOI: 10.1007/s00420-014-0960-7

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  31 in total

1.  Diagnosis and initial management of nonmalignant diseases related to asbestos.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2004-09-15       Impact factor: 21.405

2.  Sense of control and wellbeing decades after exposure to blue asbestos at Wittenoom, Western Australia.

Authors:  Alison Reid; Helman Alfonso; Justin S S Ti; Evan Wong; Nick de Klerk; Arthur W Musk
Journal:  Int J Occup Environ Health       Date:  2012 Apr-Jun

3.  Mortality in miners and millers of crocidolite in Western Australia.

Authors:  B K Armstrong; N H de Klerk; A W Musk; M S Hobbs
Journal:  Br J Ind Med       Date:  1988-01

4.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  B Gandek; J E Ware; N K Aaronson; G Apolone; J B Bjorner; J E Brazier; M Bullinger; S Kaasa; A Leplege; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Reactions of asbestos-exposed workers to notification and screening.

Authors:  B E Meyerowitz; C D Sullivan; C L Premeau
Journal:  Am J Ind Med       Date:  1989       Impact factor: 2.214

6.  Dyspnoea and quality of life in older people at home.

Authors:  S F Ho; M S O'Mahony; J A Steward; P Breay; M Buchalter; M L Burr
Journal:  Age Ageing       Date:  2001-03       Impact factor: 10.668

7.  Impact of the Hawthorne effect in a longitudinal clinical study: the case of anesthesia.

Authors:  D De Amici; C Klersy; F Ramajoli; L Brustia; P Politi
Journal:  Control Clin Trials       Date:  2000-04

Review 8.  Relations between asthma and psychological distress: an old idea revisited.

Authors:  Ryan J Van Lieshout; Glenda M Macqueen
Journal:  Chem Immunol Allergy       Date:  2012-06-26

9.  Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease.

Authors:  S Mukherjee; N de Klerk; L J Palmer; N J Olsen; S C Pang; A William Musk
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

Review 10.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16
View more
  1 in total

1.  Are the knowledge of non-malignant asbestos-related diseases and lung function impairment differentially associated with psychological well-being? A cross-sectional study in formerly asbestos-exposed workers in Germany.

Authors:  Jessica Lang; Michael K Felten; Thomas Kraus
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.